Status: current, Defined. Date: 31-Jan 2019. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3206731000168115 | chondroitin sulfate + hyaluronic acid (medicinal product) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 3206741000168112 | hyaluronic acid + chondroitin sulfate | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| hyaluronic acid + chondroitin sulfate | Is a | hyaluronic acid | true | Inferred relationship | Some | ||
| hyaluronic acid + chondroitin sulfate | has intended active ingredient | chondroitin sulfate | true | Inferred relationship | Some | 1 | |
| hyaluronic acid + chondroitin sulfate | has intended active ingredient | hyaluronic acid | true | Inferred relationship | Some | 2 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| hyaluronate sodium 1.6% (800 mg/50 mL) + sodium chondroitin sulfate 2% (1 g/50 mL) injection, syringe | Is a | True | hyaluronic acid + chondroitin sulfate | Inferred relationship | Some |
Reference Sets
Medicinal product reference set
FHIR